Financial News
Ocugen Inc (NQ: OCGN )
1.300
+0.030
(+2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Headline News about Ocugen Inc
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/microscope-3184432_1920_206.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600gene.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
Ocugen, Inc. (OCGN) Q2 2021 Earnings Call Transcript
August 06, 2021
Via The Motley Fool
Topics
Earnings
Exposures
Financial
![](https://g.foolcdn.com/editorial/images/638015/gettyimages-1298099790.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1917.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/eye-691269_1920_14.jpg)
![](https://investorplace.com/wp-content/uploads/2021/04/coronavirus-vaccine-2.jpg)
![](https://g.foolcdn.com/editorial/images/636342/people-crowding-around-a-computer.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2020/06/covid-1600.jpg)
![](https://g.foolcdn.com/editorial/images/635213/child-getting-a-jab-from-a-medical-professional.jpg)
![](https://investorplace.com/wp-content/uploads/2021/06/vaccine-covid-1600.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_247.png)
![](https://g.foolcdn.com/editorial/images/634214/gettyimages-1296010642.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-866550_1920_1_18.jpg)
![](https://g.foolcdn.com/editorial/images/633563/covid-19-vaccine-montage.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min.jpg)
![](https://g.foolcdn.com/editorial/images/633252/gettyimages-1298099807.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/syringe-1884758_1920_93.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-1.jpg)
![](https://investorplace.com/wp-content/uploads/2020/04/vaccine-2.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_918.png)
Ocugen Preps US Filings For COVID-19 Vaccine As New Data Shows Overall Efficacy Of Around 79%
July 06, 2021
Via Benzinga
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.